Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WELM Ventures is a biotechnology venture studio dedicated to the creation and development of companies focused on longevity and geroscience. The firm identifies breakthrough scientific research targeting the fundamental mechanisms of aging and provides the operational and financial framework to translate these findings into therapeutic interventions. By leveraging a team of experienced drug developers and entrepreneurs, WELM Ventures aims to address age-related diseases and extend healthy human lifespan. The company's portfolio encompasses various therapeutic modalities, including small molecules and genetic medicines, aimed at reversing or slowing biological aging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WELM Ventures.